Wipfli Financial Advisors’s Zimmer Biomet ZBH Stock Holding History

Wipfli Financial Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$90K	Buy	+859	New	+$94.3K	0.01%	780

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wipfli Financial Advisors's ZBH Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Zimmer Biomet (ZBH) in Q3 2022: 859 shares worth $90K. The stake represents 0.01% of the portfolio and ranks #780 among its holdings.

919 funds tracked by Wall St. Rank hold ZBH as of Q3 2022.

Wipfli Financial Advisors held 859 shares of Zimmer Biomet worth $90K as of Q3 2022.
Zimmer Biomet was a new Wipfli Financial Advisors position in Q3 2022.
Zimmer Biomet made up 0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #780 holding.
919 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.